New Advances in the Molecular Mechanisms Driving Biliary Fibrosis and Emerging Molecular Targets
Journal:
Current Drug Targets
Volume:
18
Page:
908-920
Author(s):
Alvaro Santos-Laso, Patricia Munoz-Garrido, Maialen Felipe-Agirre, Luis Bujanda, Jesus M. Banales and Maria J. Perugorria*
Biology, Epidemiology, Clinical Aspects of Hepatocellular Carcinoma and the Role of Sorafenib
Journal:
Current Drug Targets
Volume:
17
Page:
783-799
Author(s):
Gianluigi Mazzoccoli, Luca Miele, Jude Oben, Antonio Grieco and Manlio Vinciguerra
Recent Advances in Active Hepatic Targeting Drug Delivery System
Journal:
Current Drug Targets
Volume:
15
Page:
573-599
Author(s):
Yang Wang, Hongliang Du and Guangxi Zhai
Vitamin K2-Enhanced Liver Regeneration is Associated with Oval Cell Expansion and Up-Regulation of Matrilin-2 Expression in 2- AAF/PH Rat Model
Journal:
Current Molecular Medicine
Volume:
14
Page:
361-369
Author(s):
M. Lin, P. Sun, G. Zhang, X. Xu, G. Liu, H. Miao, Y. Yang, H. Xu, L. Zhang, P. Wu and M. Li
Role of Oxidative Stress and Molecular Changes in Liver Fibrosis: A Review
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
4850-4860
Author(s):
V. Sanchez-Valle, N. C. Chavez-Tapia, M. Uribe and N. Mendez-Sanchez
The Role of the Nervous System in the Regulation of Liver Cytochrome P450
Journal:
Current Drug Metabolism
Volume:
12
Page:
124-138
Author(s):
Jacek Wojcikowski and Wladyslawa Anna Daniel
Smad3-Mediated Signals Showing Similarities and Differences Between Epithelial and Mesenchymal Cells in Human Chronic Liver Diseases
Journal:
Current Enzyme Inhibition
Volume:
6
Page:
57-66
Author(s):
Koichi Matsuzaki
Renin-Angiotensin System Inhibitors as Therapeutic Alternatives in the Treatment of Chronic Liver Diseases
Journal:
Current Medicinal Chemistry
Volume:
14
Page:
2749-2754
Author(s):
Hitoshi Yoshiji, Ryuichi Noguchi, Yasuhide Ikenaka, Mitsuteru Kitade, Kosuke Kaji, Tatsuhiro Tsujimoto, Masahito Uemura and Hiroshi Fukui
Incidence of Side Effects During Therapy with Different Types of Alpha Interferon: A Randomised Controlled Trial Comparing Recombinant Alpha 2b Versus Leukocyte Interferon in the Therapy of Naive Patients with Chronic Hepatitis C
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
977-980
Author(s):
Antonio Ascione, Massimo De Luca, Giovan Giuseppe Di Costanzo, Francesco aolo Picciotto, Alfonso Galeota Lanza, Carmine Canestrini, Filomena Morisco, Concetta Tuccillo and Nicola Caporaso
Antifibrogenic Therapies in Chronic HCV Infection
Journal:
Current Drug Targets - Infectious Disorders
Volume:
1
Page:
227-240
Author(s):
I. shimizu